Authors
Latest:
Asembia AXS25: Pharmacy Perspectives on the Inflation Reduction ActExperts share operational challenges and patient care implications of the Inflation Reduction Act's (IRA) drug pricing reforms.
Latest:
Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and LevocetirizineThe FDA is warning of rare severe itching after stopping long-term use of popular allergy medications cetirizine and levocetirizine, urging patient education.
Latest:
New Therapy for Chronic Graft-Vs-Host Disease: AxatilimabAxatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
Latest:
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori InfectionFor pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Latest:
Meeting the Challenges in Behavioral Health Care With Hybrid Pharmacy ApproachThe hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.
Latest:
Dry Mouth: Its Etiology, Symptoms, and Strategies for ManagementPharmacists with a deeper knowledge of xerostomia are ideally positioned to help educate patients with dry mouth on making informed self-care decisions for effective symptom management and improved quality of life.
Latest:
Fighting the Flu With Supplements: The Pharmacist’s Patient Counseling GuideConfusing product labeling and conflicting data can create challenges for patients.
Latest:
The Evolving Fellowship Application ProcessThe process provides an opportunity for personal and professional growth.
Latest:
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary OncologistsFor more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
Latest:
What Diabetes Taught Me That Pharmacy School Did NotEmpathy is being left outside the exam room door.
Latest:
An Overview of Vitamins and Supplements in Multiple SclerosisBy examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
Removal of Phenylephrine From Nasal Decongestants Could Reshape OTC Cold RemediesIntranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Latest:
Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care SettingThis single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Latest:
A Dab of MAB: Lecanemab, Aducanumab vs Standard of Care Treatment for Alzheimer DiseasePharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.
Latest:
Clearing the Air: The Influence of Vaping on Smoking CessationPharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
Latest:
Future Management Considerations of RSVPanelists discuss the evolving management of RSV, highlighting the importance of increasing awareness and education, anticipating advances in testing, data reporting, and treatment options like monoclonal antibodies and antivirals, and considering future vaccination strategies such as booster doses to enhance prevention and patient outcomes.
Latest:
Precision Bayesian Modeling Tailors Vancomycin Dosing in Patients With ObesityThe future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.
Latest:
Clinical Insight: The Use of GLP-1 Agonist Medications for Weight LossAn increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
Latest:
Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its TreatmentNK is a degenerative corneal disease resulting from diminished corneal innervation.
Latest:
A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance ReportsThis quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.
Latest:
Empower Prospective Pharmacists through Children’s BooksThis short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
Latest:
Pharma Can Help Transform Patient Centricity in 2024True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.
Latest:
Addressing Racial Disparities in Opioid Prescriptions: The Role of Pharmacists in Achieving EquityPharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Latest:
Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical PracticeSystemic treatment options have historically been limited to traditional chemotherapy agents.
Latest:
Tackling the Growing Impact of Orphan Drug Designation and Limited Distribution Networks in OncologyPharmacy teams are learning to adapt to the challenges of limited distribution networks and orphan drug designation in oncology, with integrated pharmacy support playing a crucial role in enhancing patient access and adherence.
Latest:
Clinical Overview: Cyletzo, a Biosimilar Version of AdalimumabIndications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Latest:
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary OncologistsFor more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
